News Release

Racial, ethnic representation in US clinical trials of new drugs, biologics


Peer-Reviewed Publication

JAMA Network

What The Study Did: Researchers examined the participation of racial and ethnic populations in U.S. clinical trials from 2015 to 2019 to understand the extent to which trial participation represents the diversity of the U.S. population.

Authors: Milena Lolic, M.D., M.S., of the U.S. Food and Drug Administration in Silver Spring, Maryland, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link


Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.